An assessment of readiness for behaviour change in patients prescribed ocular hypotensive therapy (Q46570193)

23 December 2017

title

An assessment of readiness for behaviour change in patients prescribed ocular hypotensive therapy (English)

1 reference

23 December 2017

author name string

G F Schwartz

series ordinal

1

1 reference

23 December 2017

K S Plake

series ordinal

2

1 reference

23 December 2017

M A Mychaskiw

series ordinal

3

1 reference

23 December 2017

publication date

14 November 2008

1 reference

23 December 2017

published in

Eye

1 reference

23 December 2017

volume

23

1 reference

23 December 2017

issue

8

1 reference

23 December 2017

page(s)

1668-1674

1 reference

23 December 2017

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Persistence and adherence with topical glaucoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Patient persistency with ocular prostaglandin therapy: a population-based, retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Patient persistency with topical ocular hypotensive therapy in a managed care population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Compliance and persistency in glaucoma follow-up treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Persistency with latanoprost or timolol in primary open-angle glaucoma suspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Self-efficacy: toward a unifying theory of behavioral change

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Stages and processes of self-change of smoking: toward an integrative model of change

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FEYE.2008.337

21 January 2018

https://api.crossref.org/works/10.1038%2FEYE.2008.337

7 January 2021

In search of how people change. Applications to addictive behaviors

2 references

https://api.crossref.org/works/10.1038%2FEYE.2008.337

21 January 2018

https://api.crossref.org/works/10.1038%2FEYE.2008.337

7 January 2021

The transtheoretical model of health behavior change

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Compliance Barriers in Glaucoma: A Systematic Classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Development of the 25-item National Eye Institute Visual Function Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Colorectal cancer screening among low-income African Americans in East Harlem: a theoretical approach to understanding barriers and promoters to screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Patient decision making: strategies for diabetes diet adherence intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Transtheoretical model intervention for adherence to lipid-lowering drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Risk factors for noncompliance with glaucoma follow-up visits in a residents' eye clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Motivational interviewing in health promotion: it sounds like something is changing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Motivational interviewing in health settings: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

The Newcastle exercise project: a randomised controlled trial of methods to promote physical activity in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Compliance therapy in psychotic patients: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Compliance with treatment of patients with chronic open-angle glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

7 January 2021

Treatment for glaucoma: adherence by the elderly

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

7 January 2021

Patient persistency with pharmacotherapy in the management of glaucoma

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

7 January 2021

Efficacy of a transtheoretical model-based expert system for antihypertensive adherence

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

7 January 2021

On white-coat effects and the electronic monitoring of compliance

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

7 January 2021

Compliance declines between clinic visits

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

7 January 2021

Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy?

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

7 January 2021

A brief smoking cessation intervention for women in low-income planned parenthood clinics

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

7 January 2021

Randomised controlled trial of compliance therapy. 18-month follow-up

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

7 January 2021

Compliance and viewpoint of glaucoma patients in Greece

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

7 January 2021

Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

7 January 2021

Physician beliefs and behaviors related to glaucoma treatment adherence: the Glaucoma Adherence and Persistency Study

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.337

7 January 2021

Identifiers

DOI

10.1038/EYE.2008.337

1 reference

23 December 2017

1 reference

23 December 2017